Market Place
Sourcing Support
FDA approvals rise 49% in 2023; CRISPR’s gene editing therapy sees light of day
In 2022, when the
US Food and Drug Administration (FDA) was reeling under the impact of the
pandem
Job cuts double in 2023; Pfizer, BMS, Novartis, Biogen downsize to cut costs
The year 2023 has
seen considerable job cuts by biopharmaceutical companies. While layoffs have
be
